Helius medical technologies.

Nov 6, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Helius medical technologies. Things To Know About Helius medical technologies.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s...Helius Medical Technologies has extended by six months a program that allows multiple sclerosis (MS) patients in the U.S. to access its Portable Neuromodulation Stimulator (PoNS) device at a ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...

Exhibit 10.1. AMENDMENT 2. TO. HELIUS MEDICAL TECHNOLOGIES, INC. 2018 OMNIBUS INCENTIVE PLAN RECITALS A.Helius Medical Technologies, Inc., a Delaware corporation (the “Company”) sponsors the Helius Medical Technologies, Inc. 2018 Omnibus Incentive Plan (as previously amended by Amendment No. 1, the “Plan”). …

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

NEWTOWN, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended June 30, 2023.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Ex 10.1. Separation AND Release Agreement. This Separation and Release Agreement (this “Agreement”) is made and entered into by and between Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), and Joyce LaViscount (“Executive”).Capitalized terms used but not defined in this Agreement will have the meanings ascribed to them in …Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform ...Helius Medical Technologies. The Newtown medical technology company published study results demonstrating its portable neuromodulation stimulator, or PoNS, can “drastically” improve return-to ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...In this Annual Report on Form 10-K, (“Form 10-K”) unless otherwise specified, references to “we,” “us,” “our,” “Helius” or “the Company” mean Helius Medical Technologies, Inc. and its wholly owned subsidiaries, Helius Medical, Inc, (“HMI”), Helius Medical Technologies (Canada), Inc., (“HMC”), Helius NeuroRehab, Inc., and Helius …Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ …View the latest Helius Medical Technologies Inc. (HSDT) stock price, news, historical charts, analyst ratings and financial information from WSJ.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. ...16 thg 11, 2023 ... HELIUS TECHNOLOGIES PTE. LTD. Helius Technologies is a global ... Healthcare. Our objective is to be a solutions partner for our customers by ...Nov 9, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ...As of September 30, 2023, we had $6.6 million in cash and no debt and $4 million in proceeds receivable from warrant exercises as of September 30, 2023, and we expect our cash runway to extend ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the …Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M SA News Mon, Mar. 14, 2022 Helius Medical rallies on issuance of U.S. Patent for wireless PoNSHelius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius has studied the PoNS® to determine whether its use in combination Research - Helius Medical Technologies Our Research includes Helius-sponsored Clinical Trials and future PoNS Therapy studies on neurological diseases and disorders, such as stroke, multiple sclerosis and cerebral palsy.Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ...

Nov 17, 2022 · Earnings Estimate Revisions for Helius Medical Technologies, Inc. For the fiscal year ending December 2022, this company is expected to earn -$1.75 per share, which is a change of 76.3% from the ...

See full list on heliusmedical.com

About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ...Aug 15, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helios Technologies, Inc. (NYSE:HLIO) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Greetings and welcome to the Helios Technologies Third Quarter 2023 Financial Results Conference Call.Contact Helius Our Headquarters642 Newtown Yardley Rd., Ste 100Newtown, PA 18940Phone: +1 877-564-0008 The Portable Neuromodulation Stimulator (PoNS®) is an authorized medical device in the US. The PoNS device is indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS) and is to be used Helios Technologies, Inc. (NYSE:HLIO) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Greetings and welcome to the Helios Technologies Third Quarter 2023 Financial Results Conference Call.AI is frequently cited as a miracle worker in medicine, especially in screening processes, where machine learning models boast expert-level skills in detecting problems. But like so many technologies, it’s one thing to succeed in the lab, q...DELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100Mar 2, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Welcome to the fourth quarter and year-end 2022 Earnings Conference Call for Helius Medical Technologies. This is Michelle Bilski of Insight Communications, Investor Relations for Helius. With me ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with …

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies last released its earnings results on November 9th, 2023. The reported ($5.49) earnings per share for the quarter. The firm earned $0.14 …As previously disclosed, the employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. (the “Company”) ended on July 20, 2021 (the “Separation Date”). In connection with Ms. LaViscount’s notice of intent to resign for “Good Reason” under her employment agreement dated October 19, 2015, as …Instagram:https://instagram. trustmark stockomicstock dividend payout dateslos angeles county eviction moratorium Medical assistants are an important part of the healthcare industry, providing vital support to physicians and other medical professionals. But how much do medical assistants make? The answer depends on a variety of factors, including exper...Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences. NEWTOWN, Pa., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, … how do you buy vanguard index fundsgoldback money Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... united tractor Due to rapid developments in technology, many people are now able to visit their doctors and other healthcare providers without ever leaving their homes. This form of remote medical meeting is known as telemedicine, and it’s one of the fast...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...